---
figid: PMC3304564__ajcr0002-0178-f1
figlink: /pmc/articles/PMC3304564/figure/fig01/
number: F1
caption: 'The PI3K/AKT signaling module and cross-talk with other pathway. Upon binding
  of growth factors to receptor tyrosine kinases (RTK) a cascade of events are triggered
  resulting in the activation of PI3Kinase and subsequent AKT activation (module I).
  This cascade leads to inhibition of pro-apoptotic signaling molecules (BAD, BIM,
  BAX, Cas-pase 9) or induction of anti-apoptotic Bcl-2, Mcl-1, BCL-XL, Bcl-w conferring
  a growth advantage to the tumor cells. One of the major targets of AKT is the mTOR
  (module Ii) which is also implicated in cell growth and metabolism. The intricacy
  of the AKT pathway is further complicated by its cross-talk, via various positive
  and negative regulatory feedback loops, with multiple major cell survival pathways
  including: NF-κB (module II), RAS/RAF/MEK/ERK MAPK (module III), p38MAPK (module
  IV), JNK MAPK (module V). This elaborate network of signaling pathways will amplify
  the anti-apoptotic signaling and confer a resistant phenotype to the malignant melanoma
  cells.'
pmcid: PMC3304564
papertitle: Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling
  module in melanoma therapy.
reftext: Ali R Jazirehi, et al. Am J Cancer Res. 2012;2(2):178-191.
pmc_ranked_result_index: '19777'
pathway_score: 0.9468912
filename: ajcr0002-0178-f1.jpg
figtitle: PI3K/AKT signaling module and cross-talk with other pathway
year: '2012'
organisms:
- Homo sapiens
ndex: 0f65ab37-defb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3304564__ajcr0002-0178-f1.html
  '@type': Dataset
  description: 'The PI3K/AKT signaling module and cross-talk with other pathway. Upon
    binding of growth factors to receptor tyrosine kinases (RTK) a cascade of events
    are triggered resulting in the activation of PI3Kinase and subsequent AKT activation
    (module I). This cascade leads to inhibition of pro-apoptotic signaling molecules
    (BAD, BIM, BAX, Cas-pase 9) or induction of anti-apoptotic Bcl-2, Mcl-1, BCL-XL,
    Bcl-w conferring a growth advantage to the tumor cells. One of the major targets
    of AKT is the mTOR (module Ii) which is also implicated in cell growth and metabolism.
    The intricacy of the AKT pathway is further complicated by its cross-talk, via
    various positive and negative regulatory feedback loops, with multiple major cell
    survival pathways including: NF-κB (module II), RAS/RAF/MEK/ERK MAPK (module III),
    p38MAPK (module IV), JNK MAPK (module V). This elaborate network of signaling
    pathways will amplify the anti-apoptotic signaling and confer a resistant phenotype
    to the malignant melanoma cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOSL1
  - FOS
  - NRAS
  - JUNB
  - FOXO4
  - FOXO6
  - BAX
  - AKT2
  - AKT1
  - KRAS
  - MAPK1
  - FOSL2
  - MAP2K2
  - MAPK3
  - FOSB
  - MAP2K1
  - TSC2
  - JUND
  - FOXO3
  - HRAS
  - BRAF
  - PTEN
  - AKT3
  - DHX9
  - ARAF
  - RHEB
  - JUN
  - BCL2L11
  - RAF1
  - FOXO1
  - Glucose
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Rha
  symbol: RHA
  source: hgnc_alias_symbol
  hgnc_symbol: DHX9
  entrez: '1660'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Foxo
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3304564__F1
redirect_from: /figures/PMC3304564__F1
figtype: Figure
---
